Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Deficiency)

v3.19.3
Condensed Consolidated Statements of Equity (Deficiency) - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Jun. 30, 2018   $ 16 $ 104,408 $ (30) $ (88,228) $ (2) $ 16,164
Balance (in shares) at Jun. 30, 2018 12 16,040          
Sale of common stock   $ 1 1,349       1,350
Sale of common stock (in shares)   1,500          
Costs to raise capital     (159)       (159)
Conversion of preferred stock to common stock   $ 1 (1)        
Conversion of preferred stock to common stock (in shares) (1) 797          
Share-based compensation     73       73
Foreign currency translation adjustment       (1)     (1)
Net loss         (4,398) (1) (4,399)
Balance at Sep. 30, 2018   $ 18 105,670 (31) (92,626) (3) 13,028
Balance (in shares) at Sep. 30, 2018 11 18,337          
Balance at Jun. 30, 2019   $ 20 108,295 (31) (105,821) (6) 2,457
Balance (in shares) at Jun. 30, 2019 10 20,152          
Conversion of preferred stock to common stock   $ 4 (4)        
Conversion of preferred stock to common stock (in shares) (4) 4,000          
Share-based compensation     68       68
Foreign currency translation adjustment       (1)     (1)
Net loss $ 0 $ 0 0 0 (4,463) (1) (4,464)
Balance at Sep. 30, 2019 $ 0 $ 24 $ 108,359 $ (32) $ (110,284) $ (7) $ (1,940)
Balance (in shares) at Sep. 30, 2019 6 24,152